Pictet Asset Management (Switzerland)’s Amedisys AMED Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$291K	Sell	3,183 -69,623	-96%	-$5.71M	﹤0.01%	1524
2023 Q1	$5.35M	Sell	72,806 -73,935	-50%	-$6.4M	0.01%	773
2022 Q4	$12.3M	Buy	146,741 +59,009	+67%	+$5.32M	0.02%	549
2022 Q3	$8.49M	Sell	87,732 -10,348	-11%	-$1.23M	0.01%	621
2022 Q2	$10.3M	Sell	98,080 -378,285	-79%	-$48.3M	0.01%	588
2022 Q1	$82.1M	Buy	476,365 +35,352	+8%	+$5.28M	0.09%	246
2021 Q4	$71.4M	Buy	441,013 +50,603	+13%	+$8.13M	0.07%	284
2021 Q3	$58.2M	Buy	+390,410	New	+$81.2M	0.06%	308

Other funds holding AMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s AMED Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its Amedisys (AMED) stake by 96% in Q2 2023, selling an estimated $5.71M and leaving 3,183 shares worth $291K. The position accounts for ﹤0.01% of the portfolio, ranked #1524.

Pictet Asset Management (Switzerland) first reported a position in AMED in Q3 2021 and has held it in 8 quarters since. The position peaked at $82.1M in Q1 2022. 302 funds tracked by Wall St. Rank hold AMED as of Q2 2023.

Pictet Asset Management (Switzerland) held 3,183 shares of Amedisys worth $291K as of Q2 2023.
Pictet Asset Management (Switzerland) sold 69,623 Amedisys shares in Q2 2023, an estimated $5.71M.
Amedisys made up ﹤0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #1524 holding.
Pictet Asset Management (Switzerland) first reported a position in Amedisys in Q3 2021 and has held it in 8 quarters since.
Pictet Asset Management (Switzerland)'s Amedisys position peaked at $82.1M in Q1 2022.
302 funds tracked by Wall St. Rank held Amedisys as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.